R. Meli

Articles in Scholarly Journals [Incomplete List]

  1. AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: Role for cannabinoid receptors
    Neuropharmacology, vol. 54, no. 3, pp. 521–529, 2008
  2. Evaluation of Placental Protein Modifications in Normotensive and Spontaneously Hypertensive Rats
    Placenta, vol. 29, no. 5, pp. 429–435, 2008
  3. Evidence for the Role of Mitogen-Activated Protein Kinase Signaling Pathways in the Development of Spinal Cord Injury
    Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 1, pp. 100–114, 2008
  4. Effects of Palmitoylethanolamide on Signaling Pathways Implicated in the Development of Spinal Cord Injury
    Journal of Pharmacology and Experimental Therapeutics, vol. 326, no. 1, pp. 12–23, 2008
  5. Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF- 
    Journal of Leukocyte Biology, vol. 81, no. 4, pp. 1032–1043, 2007
  6. Acute Intracerebroventricular Administration of Palmitoylethanolamide, an Endogenous Peroxisome Proliferator-Activated Receptor-  Agonist, Modulates Carrageenan-Induced Paw Edema in Mice
    Journal of Pharmacology and Experimental Therapeutics, vol. 322, no. 3, pp. 1137–1143, 2007
  7. Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells
    Journal of Pineal Research, vol. 0, no. 0, pp. 070907020816001–???, 2007
  8. Maternal adaptations to pregnancy in spontaneously hypertensive rats: leptin and ghrelin evaluation
    Journal of Endocrinology, vol. 194, no. 3, pp. 611–619, 2007
  9. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma
    Neuroscience, vol. 150, no. 1, pp. 168–181, 2007
  10. Protective effect of Hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome: Relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity
    Nitric Oxide, vol. 16, no. 1, pp. 118–130, 2007
  11. Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein
    European Journal of Pharmacology, vol. 549, no. 1-3, pp. 149–156, 2006
  12. Expression of COX-2 and hsp72 in peritoneal macrophages after an acute ochratoxin A treatment in mice
    Life Sciences, vol. 79, no. 13, pp. 1242–1247, 2006
  13. Leptin induces nitric oxide synthase type II in C6 glioma cellsRole for nuclear factor-κB in hormone effect
    Neuroscience Letters, vol. 396, no. 2, pp. 121–126, 2006
  14. Modulation of Neuropathic and Inflammatory Pain by the Endocannabinoid Transport Inhibitor AM404 [N-(4-Hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]
    Journal of Pharmacology and Experimental Therapeutics, vol. 317, no. 3, pp. 1365–1371, 2006
  15. Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor- 
    Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 3, pp. 1051–1061, 2006
  16. GREEN TEA POLYPHENOL EXTRACT ATTENUATES ZYMOSAN-INDUCED NON-SEPTIC SHOCK IN MICE
    Shock, vol. 26, no. 4, pp. 402–409, 2006
  17. CYTOKINE-TRIGGERED DECREASES IN LEVELS OF PHOSPHORYLATED EUKARYOTIC INITIATION FACTOR 4G IN SKELETAL MUSCLE DURING SEPSIS
    Shock, vol. 26, no. 6, pp. 631–636, 2006
  18. Peroxisome Proliferator-Activated Receptors and Shock State
    TheScientificWorldJOURNAL, vol. 6, pp. 1770–1782, 2006
  19. Effects of combination of melatonin and dexamethasone on acute lung injury in a mice model of carrageenan-induced pleurisy
    Journal of Pineal Research, vol. 41, no. 3, pp. 228–237, 2006
  20. Melatonin modulates signal transduction pathways and apoptosis in experimental colitis
    Journal of Pineal Research, vol. 41, no. 4, pp. 363–373, 2006
  21. Estrogen Receptor Antagonist Fulvestrant (ICI 182,780) Inhibits the Anti-Inflammatory Effect of Glucocorticoids
    Molecular Pharmacology, vol. 71, no. 1, pp. 132–144, 2006
  22. Inverse Shift in Circulating Corticosterone and Leptin Levels Elevates Hypothalamic Deiodinase Type 2 in Fasted Rats
    Endocrinology, vol. 146, no. 6, pp. 2827–2833, 2005
  23. Raloxifene, a Selective Estrogen Receptor Modulator, Reduces Carrageenan-Induced Acute Inflammation in Normal and Ovariectomized Rats
    Endocrinology, vol. 146, no. 8, pp. 3301–3308, 2005
  24. Suppression of hypothalamic deiodinase type II activity blunts TRH mRNA decline during fasting
    FEBS Letters, vol. 579, no. 21, pp. 4654–4658, 2005
  25. Effect of methylguanidine in carrageenan-induced acute inflammation in the rats
    European Journal of Pharmacology, vol. 484, no. 2-3, pp. 341–350, 2004
  26. Estrogen and Raloxifene Modulate Leptin and Its Receptor in Hypothalamus and Adipose Tissue from Ovariectomized Rats
    Endocrinology, vol. 145, no. 7, pp. 3115–3121, 2004
  27. Hypothalamic type II iodothyronine deiodinase: a light and electron microscopic study
    Brain Research, vol. 976, no. 1, pp. 130–134, 2003
  28. Effect of fumonisin B1 on structure and function of macrophage plasma membrane
    Toxicology Letters, vol. 129, no. 3, pp. 181–187, 2002
  29. Synthesis and in vitro chemical and enzymatic stability of glycosyl 3′-azido-3′-deoxythymidine derivatives as potential anti-HIV agents
    European Journal of Pharmaceutical Sciences, vol. 16, no. 3, pp. 167–174, 2002
  30. Leptin potentiates IFN-γ-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A.1
    British Journal of Pharmacology, vol. 137, no. 6, Article ID 0704903, 5 pages, 2002
  31. In-vivo and in-vitro anti-inflammatory effect of <I>Echinacea purpurea</I> and <I>Hypericum perforatum</I>
    Journal of Pharmacy and Pharmacology, vol. 54, no. 10, pp. 1379–1383, 2002
  32. Thrombin and PAR-1 acitvating peptide increase iNOS expression in cytokine-stimulated C6 glioma cells
    Journal of Neurochemistry, vol. 79, no. 3, pp. 556–563, 2001
  33. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1
    Life Sciences, vol. 68, no. 8, pp. 921–931, 2001
  34. Analgesia and cyclo-oxygenase inhibitors
    Digestive and Liver Disease, vol. 33, pp. S8–S11, 2001
  35. Protective effect of a PAR2-activating peptide on histamine-induced bronchoconstriction in guinea-pig
    British Journal of Pharmacology, vol. 132, no. 6, Article ID 0703934, 5 pages, 2001
  36. Effect of fumonisin B1 on inducible nitric oxide synthase and cyclooxygenase-2 in LPS-stimulated J774A.1 cells
    Life Sciences, vol. 67, no. 23, pp. 2845–2853, 2000
  37. Prolactin Induction of Nitric Oxide Synthase in Rat C6 Glioma Cells
    Journal of Neurochemistry, vol. 73, no. 6, pp. 2272–2277, 1999
  38. Preparation and local anaesthetic activity of benzotriazinone and benzoyltriazole derivatives
    European Journal of Medicinal Chemistry, vol. 34, no. 12, pp. 1043–1051, 1999
  39. Prolactin modulation of nitric oxide and TNF-a production by peripheral neutrophils in rats
    Life Sciences, vol. 61, no. 14, pp. 1395–1403, 1997
  40. Synthesis and pharmacological evaluation of a set of -[2-(alkylamino)ethyl]benzotriazol--yl isobutyramides acting as local anesthetics
    European Journal of Medicinal Chemistry, vol. 31, no. 2, pp. 99–104, 1996
  41. The effect of age and sex on the expression of prolactin binding activity in the chicken bursa of fabricius
    Life Sciences, vol. 59, no. 21, pp. 1803–1808, 1996
  42. Recombinant human prolactin induces protection against Salmonella typhimurium infection in the mouse: role of nitric oxide
    Immunopharmacology, vol. 34, no. 1, pp. 1–7, 1996
  43. Synthesis and biological activity of benzotriazole derivatives structurally related to trazodone
    European Journal of Medicinal Chemistry, vol. 30, no. 1, pp. 77–84, 1995
  44. Synthesis, local anesthetic activity and QSAR studies for a set of -[2-(alkylamino)ethyl]benzotriazol--yl acetamides
    European Journal of Medicinal Chemistry, vol. 30, no. 7-8, pp. 603–608, 1995
  45. Regulation of prolactin receptor mRNA expression in peripheral lymphocytes in rats in response to changes in serum concentrations of prolactin
    Endocrinology, vol. 136, no. 10, pp. 4713–4716, 1995
  46. Synthesis and trazodone-like pharmacological profile of 1- and 2-[3-[4-(X)-1-piperazinyl]-propyl]-benzotriazoles
    European Journal of Medicinal Chemistry, vol. 28, no. 12, pp. 969–974, 1993
  47. Effects of Flavonoids on Small Intestinal Transit in Mice
    Pharmacological Research, vol. 27, pp. 37–38, 1993
  48. Prolactin protection against lethal effects of Salmonella typhimurium
    Life Sciences, vol. 53, no. 12, pp. 981–989, 1993
  49. Further evidence for the involvement of prolactin in the inflammatory response
    Life Sciences, vol. 53, no. 6, pp. PL105–PL110, 1993
  50. Prolactin treatment reduces the mortality rate in mice infected with salmonella typhimurium
    Pharmacological Research, vol. 26, p. 245, 1992
  51. Pharmacological evaluation of benzotriazole derivatives structurally related to trazodone
    Pharmacological Research, vol. 26, p. 266, 1992
  52. Inhibitory action of quercetin on intestinal transit in mice
    Phytotherapy Research, vol. 4, no. 5, pp. 201–202, 1990
  53. Inhibitory effects of fungi on aggregation of rabbit platelets and rat polymorphonuclear leucocytes in vitro
    Journal of Ethnopharmacology, vol. 22, no. 1, pp. 91–99, 1988
  54. Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin
    Journal of Pharmacological Methods, vol. 19, no. 1, pp. 89–91, 1988
  55. Evidence against a Dependence of the Senna Effect on Prostaglandin Formation
    Pharmacology, vol. 36, no. 1, pp. 92–97, 1988
  56. Distinct inhibition of membrane-bound and lysosomal phospholipase A2 by glucocorticoid-induced proteins
    Biochemical Pharmacology, vol. 33, no. 9, pp. 1445–1450, 1984